Marpai (MRAI) Competitors $1.23 +0.03 (+2.50%) As of 09/12/2025 03:34 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock MRAI vs. ATPC, BDSX, PIII, EUDA, BMGL, KDLY, CCM, MGRX, BRTX, and BGLCShould you be buying Marpai stock or one of its competitors? The main competitors of Marpai include Agape ATP (ATPC), Biodesix (BDSX), P3 Health Partners (PIII), EUDA Health (EUDA), Basel Medical Group (BMGL), Kindly MD (KDLY), Concord Medical Services (CCM), Mangoceuticals (MGRX), Biorestorative Therapies (BRTX), and BioNexus Gene Lab (BGLC). These companies are all part of the "healthcare" industry. Marpai vs. Its Competitors Agape ATP Biodesix P3 Health Partners EUDA Health Basel Medical Group Kindly MD Concord Medical Services Mangoceuticals Biorestorative Therapies BioNexus Gene Lab Marpai (NASDAQ:MRAI) and Agape ATP (NASDAQ:ATPC) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, valuation, media sentiment, profitability and risk. Which has more volatility and risk, MRAI or ATPC? Marpai has a beta of 4.66, indicating that its stock price is 366% more volatile than the S&P 500. Comparatively, Agape ATP has a beta of -0.98, indicating that its stock price is 198% less volatile than the S&P 500. Do insiders and institutionals have more ownership in MRAI or ATPC? 49.8% of Marpai shares are held by institutional investors. Comparatively, 0.0% of Agape ATP shares are held by institutional investors. 46.1% of Marpai shares are held by insiders. Comparatively, 9.7% of Agape ATP shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is MRAI or ATPC more profitable? Marpai has a net margin of -85.70% compared to Agape ATP's net margin of -183.13%. Marpai's return on equity of 0.00% beat Agape ATP's return on equity.Company Net Margins Return on Equity Return on Assets Marpai-85.70% N/A -100.23% Agape ATP -183.13%-20.32%-18.55% Does the media refer more to MRAI or ATPC? In the previous week, Agape ATP had 3 more articles in the media than Marpai. MarketBeat recorded 3 mentions for Agape ATP and 0 mentions for Marpai. Agape ATP's average media sentiment score of 1.68 beat Marpai's score of 0.00 indicating that Agape ATP is being referred to more favorably in the news media. Company Overall Sentiment Marpai Neutral Agape ATP Very Positive Which has higher valuation & earnings, MRAI or ATPC? Agape ATP has lower revenue, but higher earnings than Marpai. Agape ATP is trading at a lower price-to-earnings ratio than Marpai, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMarpai$34.87M0.61-$28.75M-$0.87-1.41Agape ATP$1.32M50.05-$2.47M-$0.41-3.22 SummaryMarpai beats Agape ATP on 7 of the 13 factors compared between the two stocks. Get Marpai News Delivered to You Automatically Sign up to receive the latest news and ratings for MRAI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MRAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MRAI vs. The Competition Export to ExcelMetricMarpaihealth & allied services, not elsewhere classified IndustryBusiness SectorNASDAQ ExchangeMarket Cap$21.24M$86.09M$26.38B$10.13BDividend YieldN/AN/A2.74%4.60%P/E Ratio-0.470.8227.1825.93Price / Sales0.610.441,176.90183.79Price / CashN/A2.8027.3460.44Price / Book-0.720.177.766.29Net Income-$28.75M$43.11M$199.14M$270.77M7 Day Performance-8.21%-4.32%9.79%3.88%1 Month Performance-14.35%15.08%18.51%4.88%1 Year Performance141.18%22.61%52.40%26.01% Marpai Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRAIMarpaiN/A$1.23+2.5%N/A+117.7%$21.24M$34.87M-0.47150ATPCAgape ATP0.8201 of 5 stars$1.29flatN/A-8.9%$64.51M$1.32M-3.1540News CoveragePositive NewsShort Interest ↓Gap DownBDSXBiodesix3.4138 of 5 stars$0.46+7.4%$1.75+277.0%-79.2%$63.38M$71.32M-1.60220News CoverageAnalyst UpgradeStock SplitPIIIP3 Health Partners2.8403 of 5 stars$8.79+0.1%$16.25+84.9%-65.6%$63.11M$1.50B-0.19500Positive NewsEUDAEUDA Health0.5261 of 5 stars$1.47-2.0%N/A-69.6%$55.74M$4.01M0.002Short Interest ↑BMGLBasel Medical GroupN/A$1.95flatN/AN/A$35.99MN/A0.0036KDLYKindly MDN/A$4.56+11.8%N/A+218.1%$27.46M$2.47M-5.92N/AGap DownHigh Trading VolumeCCMConcord Medical Services1.3687 of 5 stars$5.55-4.1%N/A+7.7%$25.07M$52.60M0.00970Short Interest ↓Gap DownMGRXMangoceuticals0.6712 of 5 stars$2.30-3.0%N/A-96.2%$24.97M$620K-0.603News CoverageShort Interest ↑BRTXBiorestorative Therapies2.3858 of 5 stars$1.57-2.5%N/A+2.7%$12.85M$605.20K-1.247Positive NewsBGLCBioNexus Gene Lab0.6286 of 5 stars$4.41-11.3%N/A+39.6%$8.92M$9.55M0.0030Gap Down Related Companies and Tools Related Companies Agape ATP Competitors Biodesix Competitors P3 Health Partners Competitors EUDA Health Competitors Basel Medical Group Competitors Kindly MD Competitors Concord Medical Services Competitors Mangoceuticals Competitors Biorestorative Therapies Competitors BioNexus Gene Lab Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MRAI) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marpai, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marpai With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
